Home/Filings/4/0001209191-17-054195
4//SEC Filing

JENKINSON PAUL L 4

Accession 0001209191-17-054195

CIK 0001510580other

Filed

Sep 26, 8:00 PM ET

Accepted

Sep 27, 9:39 PM ET

Size

7.2 KB

Accession

0001209191-17-054195

Insider Transaction Report

Form 4
Period: 2017-09-25
JENKINSON PAUL L
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2017-09-25+2,50010,410 total
  • Sale

    Common Stock

    2017-09-25$179.66/sh948$170,3219,462 total
Holdings
  • Common Stock

    (indirect: See footnote)
    3,000
Footnotes (3)
  • [F1]Includes 430 shares acquired under the 2014 Employee Stock Purchase Plan on August 18, 2017.
  • [F2]The shares were sold to cover the tax obligation that occurred upon the vesting of an RSU.
  • [F3]The shares are held by The Amended & Restated Paul and Monika Jenkinson Family Trust Dated July 25, 2012.

Issuer

Kite Pharma, Inc.

CIK 0001510580

Entity typeother

Related Parties

1
  • filerCIK 0001674528

Filing Metadata

Form type
4
Filed
Sep 26, 8:00 PM ET
Accepted
Sep 27, 9:39 PM ET
Size
7.2 KB